Inova Health System
Also known as: Donald Trump, MD | Inova Alexandria | Inova Fairfax Hospital | Inova Fairfax Hospital Cancer Center | Inova Fairfax Medical Campus | Inova Healthcare Services | Inova Health Care Services | Inova Health Care System | Inova Health Care Systems | Inova Health System | Inova Health Systems | Inova Heart and Vascular Institute | Inova Schar Cancer Institute | Inova Translational Medicine Institute | Mount Vernon Cancer Centre | Mount Vernon Cancer Centre at Mount Vernon Hospital | Mount Vernon Hospital | Palak Shah, MD
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1995Last known activity
Oct 7, 2025
Timeline
1950s
- Jun 1, 1956
Inova Health System— Founded
Drugs by trial phase (79 distinct, 51 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (28 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Anus Neoplasms
- Arterial Occlusive Diseases
- Arteriosclerosis
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cardiovascular Diseases
- Cerebral Infarction
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Embolism
- Fallopian Tube Neoplasms
- Glioblastoma
- Heart Diseases
- Heart Failure
- Hypertension
- Hypertension, Pulmonary
- Infarction
- Infections
- Influenza, Human
- Ischemia
- Kidney Neoplasms
- Lung Diseases, Obstructive
- Lymphoma
- Melanoma
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms
- Ovarian Neoplasms
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Peritoneal Neoplasms
- Postoperative Pain
- Prostatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Embolism
- Rectal Neoplasms
- Respiratory Aspiration
- Sarcoidosis
- Stroke
- Thromboembolism
- Urinary Bladder Neoplasms
- Vascular Diseases
Recent trials (50)
- NCT07023666Lead sponsorPhase 2Oct 7, 2025
- NCT07023666OfficialPhase 2Oct 7, 2025
- NCT06789757Lead sponsorPhase 2Feb 25, 2025
- NCT06501989Lead sponsorPhase 2Jan 15, 2025
- NCT06501989OfficialPhase 2Jan 15, 2025
- NCT06564207Lead sponsorPhase 2Nov 1, 2024
- NCT06273891Lead sponsorPhase 3Mar 8, 2024
- NCT06273891Sponsor investigatorPhase 3Mar 8, 2024
- NCT06273891OfficialPhase 3Mar 8, 2024
- NCT06023199OfficialPhase 2Oct 23, 2023
- NCT06023199Lead sponsorPhase 2Oct 23, 2023
- NCT07250763Lead sponsorPhase 4Sep 20, 2023
- NCT06007846Lead sponsorPhase 2/Phase 3Jul 31, 2023
- NCT04865978Overall official - principal investigatorPhase 2Dec 1, 2021
- NCT04865978Lead sponsorPhase 2Dec 1, 2021
Details
- Founded
- Falls Church, VA, US Jun 1, 1956
- Last known activity
- Oct 7, 2025